"We are happy to sign an agreement to manufacture the oral COVID-19 antirviral medication, which is an urgent need of the hour, this is one of the most critical step towards fighting the pandemic and we are happy to contribute to the mission," Laurus Labs Founder and CEO Satyanarayana Chava said in a regulatory filing.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3rzuhsd
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Laurus Labs inks pact with MPP to produce molnupiravir
0 comments:
Post a Comment